Evidence map›Paper›PMID 19896852›Full record

ReviewTrends in microbiology2010

Functional viral metagenomics and the next generation of molecular tools.

Thomas Schoenfeld, Mark Liles, K Eric Wommack, Shawn W Polson, Ronald Godiska, David Mead

Abstract readReview
In one paragraph

Review in Trends in microbiology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
7.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 73 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. NovelFrontiers in microbiology · 2020
    Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Rapid evolution of the human gut virome.Proceedings of the National Academy of Sciences of the United States of America · 2013
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Thomas SchoenfeldLucigen Corporation, 2120 W. Greenview Drive, Suite 9, Middleton, WI 53562, USA. tschoenfeld@lucigen.com <tschoenfeld@lucigen.com>
Mark Liles
K Eric Wommack
Shawn W Polson
Ronald Godiska
David Mead
Lucigen Corporation · USAuburn University · USBiotechnology Institute · USUniversity of Delaware · US

Funding

Improved DNA Polymerases for Genomic SequencingR44HG002714 · NHGRI · LUCIGEN CORPORATION · PI SCHOENFELD, THOMAS WILLIAM · 2007 to 2008
$776k
NHGRI NIH HHS 5 R44 HG002714-03NHGRI NIH HHS R44 HG002714
6 · The paper itself

Abstract

The enzymes of bacteriophages and other viruses have been essential research tools since the first days of molecular biology. However, the current repertoire of viral enzymes only hints at their overall potential. The most commonly used enzymes are derived from a surprisingly small number of cultivated viruses, which is remarkable considering the extreme abundance and diversity of viruses revealed over the past decade by metagenomic analysis. To access the treasure trove of enzymes hidden in the global virosphere and develop them for research, therapeutic and diagnostic uses, improvements are needed in our ability to rapidly and efficiently discover, express and characterize viral genes to produce useful proteins. In this paper, we discuss improvements to sampling and cloning methods, functional and genomics-based screens, and expression systems, which should accelerate discovery of new enzymes and other viral proteins for use in research and medicine.

Indexed as

MetagenomicsAnimalsBiotechnologyCloning, MolecularGenome, ViralViral ProteinsVirusesWater MicrobiologyViral Proteins

Identifiers

PMID19896852
PMCPMC2818347
OpenAlexW2144184757

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.